Variant report
Variant | nsv981118 |
---|---|
Chromosome Location | chr6:26885645-26891196 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs534834220 | chr6:26888206-26888207 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs531988629 | chr6:26888230-26888231 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs550218585 | chr6:26888265-26888266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs189266965 | chr6:26888267-26888268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs367901657 | chr6:26888279-26888280 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs576066438 | chr6:26888280-26888281 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs563345101 | chr6:26888281-26888282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs571950179 | chr6:26888282-26888283 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs201429387 | chr6:26888288-26888289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs368201172 | chr6:26888290-26888291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs543338438 | chr6:26888292-26888293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs559632553 | chr6:26888300-26888301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs187242505 | chr6:26888304-26888305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs551561760 | chr6:26888306-26888307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs11970765 | chr6:26888333-26888334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs375653395 | chr6:26888348-26888349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs11963545 | chr6:26888351-26888352 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs200565608 | chr6:26888355-26888356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs201116154 | chr6:26888359-26888360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs113450954 | chr6:26888363-26888364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs201060145 | chr6:26888365-26888366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs202023039 | chr6:26888366-26888367 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs372556190 | chr6:26888367-26888368 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs11960986 | chr6:26888368-26888369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs11960987 | chr6:26888394-26888395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs11960988 | chr6:26888396-26888397 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs190299642 | chr6:26888398-26888399 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs12189666 | chr6:26888420-26888421 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
29 | rs199603516 | chr6:26888434-26888435 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs549231568 | chr6:26888436-26888437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs565986085 | chr6:26888548-26888549 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs534771682 | chr6:26888658-26888659 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs558027180 | chr6:26888676-26888677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs147086595 | chr6:26888727-26888728 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs537176756 | chr6:26888753-26888754 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs151076348 | chr6:26888754-26888755 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs2754647 | chr6:26888758-26888759 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs373411907 | chr6:26889000-26889001 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs532688536 | chr6:26889215-26889216 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs185834906 | chr6:26889220-26889221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs542276436 | chr6:26889230-26889231 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs190542480 | chr6:26889349-26889350 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs573210425 | chr6:26889467-26889468 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs545185589 | chr6:26889549-26889550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs565184751 | chr6:26889598-26889599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs140967207 | chr6:26889639-26889640 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs6928511 | chr6:26889645-26889646 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs182381274 | chr6:26889725-26889726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs545057387 | chr6:26889727-26889728 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs146994277 | chr6:26889734-26889735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 21569311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 21509527 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:26888200-26893800 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
2 | chr6:26889400-26893600 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
3 | chr6:26889600-26891600 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
4 | chr6:26889600-26891800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr6:26889800-26894400 | Weak transcription | Stomach Smooth Muscle | stomach |
6 | chr6:26890200-26892800 | Weak transcription | Adipose Nuclei | Adipose |
7 | chr6:26890200-26894400 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
8 | chr6:26890400-26893200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
9 | chr6:26890600-26892800 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr6:26890600-26893000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr6:26890600-26893000 | Weak transcription | Fetal Kidney | kidney |